Dermal Allograft Innovation Grants
Forecasted
Dermal Allograft Innovation Grants support researchers developing new technologies, clinical uses, and product forms for donated dermis and skin to expand reconstructive and regenerative patient care.
Funder: Musculoskeletal Transplant Foundation (MTF Biologics)
Due Dates (Anticipated): January 2027 (Application deadline)
Funding Amounts: Research grant funding for new and ongoing projects
Summary: Supports translational and clinical research advancing donated dermis and skin through new technologies, clinical uses, processing methods, and product forms.
Key Information: Applicants must be researchers at accredited institutions.
Description
The Musculoskeletal Transplant Foundation, known as MTF Biologics, offers Dermal Allograft Innovation Grants to support translational and clinical research in allograft dermis and skin. Allograft dermal matrices and skin allografts are used in reconstructive and regenerative procedures, including breast surgery, wound healing, and abdominal wall reconstruction.
The program seeks innovations beyond primarily sheet-based products that expand tissue versatility and clinical utility, improve storage and handling, and enable new clinical applications. Priorities include enabling technologies, novel clinical uses, advanced processing or delivery methods, and next-generation product forms. Examples include flowable or particulate dermal matrices, 3D-printed constructs, tissue-engineered skin, viable dermal tissues, and advanced preservation technologies.
